SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses
University of Southern California · California Institute of Technology · +4 more institutions
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently identified coronavirus that causes the respiratory disease known as coronavirus disease 2019 (COVID-19). Despite the urgent need, we still do not fully understand the molecular basis of SARS-CoV-2 pathogenesis. Here, we comprehensively define the interactions between SARS-CoV-2 proteins and human RNAs. NSP16 binds to the mRNA recognition domains of the U1 and U2 splicing RNAs and acts to suppress global mRNA splicing upon SARS-CoV-2 infection. NSP1 binds to 18S ribosomal RNA in the mRNA entry channel of the ribosome and leads to global inhibition of mRNA translation upon infection. Finally, NSP8 and NSP9 bind to the 7SL RNA in the…
Citation impact
- FWCI
- 38.93
- Percentile
- 100%
- References
- 103
Authors
22Topics & keywords
- Biology
- RNA splicing
- Translation (biology)
- RNA
- Coronavirus
- Messenger RNA
- RNA-binding protein
- Ribosome
- Good health and well-being
Funding
- FFFoundation for the National Institutes of Health
- ACAmerican Cancer Society
- NYNew York Stem Cell Foundation
- CICalifornia Institute of Technology
- WTWellcome Trust
- UOUniversity of Vermont
- HMHeritage Medical Research Institute
- CZChan Zuckerberg Initiative
- NINational Institutes of HealthAwards: HL130007, F30CA247447, U01 HL130007, UM1HL120877, U01AI1141997, P20GM125498, P30GM118228, DA040612, U54GM115516, U01 DA040612
- MRMedical Research CouncilAwards: MC_PC_19026, MC_UU_12014/10